filo/iStock via Getty Images
Johnson & Johnson (NYSE:JNJ) traded flat in the premarket as the healthcare giant started pharma earnings season on Tuesday, raising its full-year sales outlook with its Q1 results, while its sector is bracing for new tariffs under the Trump administration.